
Evidence analysis
Pancreatic cancer: The RAS paradigm shift
Pancreatic Cancer: The RAS Paradigm Shift - An Evidence Dossier Source: PLOS Medicine, article published October 29, 2026, by Samuel P. Soff and Eileen M. O’Reilly What is Established Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of…
Read →
Evidence analysis
Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial
Immunogenicity and Safety of Shorter Intradermal Rabies Vaccine Regimens in India: Evidence from a Phase 4 Trial Rabies remains a fatal viral disease with significant public health impact worldwide, especially in India, which bears a large proportion of…
Read →
Evidence analysis
Bearing witness in war zones
Bearing Witness in War Zones: An Evidence Dossier What is established Ron Haviv is an award-winning filmmaker and photographer who has documented armed conflicts worldwide for over three decades. As a co-founder of the VII Foundation, Haviv supports…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 77, Status: Authorised
Opdivo (Nivolumab) - European Public Assessment Report Evidence Dossier What is established Opdivo, whose active substance is nivolumab, is an immune checkpoint inhibitor authorized by the European Medicines Agency (EMA) for the treatment of several advanced cancers. Opdivo…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 19, Status: Authorised
Qarziba (Dinutuximab beta) for Neuroblastoma: An Evidence Dossier What is established Qarziba is a medicinal treatment authorised in the European Union for the management of neuroblastoma, a cancer of nerve cells primarily affecting children older than one year.…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 19, Status: Authorised
What is established Carvykti (ciltacabtagene autoleucel) is a genetically engineered therapy approved in the European Union for the treatment of multiple myeloma, a type of bone marrow cancer. It is authorized for adult patients whose disease has relapsed…
Read →
Evidence analysis
EMA closed on All Souls' Day, 2 November
What is established The European Medicines Agency (EMA) announced that its office will be closed on Monday, 2 November 2026, in observance of All Souls' Day. The closure period extends from 18:00 on Friday, 30 October until 08:30…
Read →
Evidence analysis
Criminal Probe Launched in South Africa Over Contraband Baobabs Bound for Georgia
Investigations Into Illegal Baobab Tree Exports From South Africa to Georgia What is established South African authorities have initiated a criminal investigation into the illegal uprooting and planned export of at least five large baobab trees from Limpopo…
Read →
Evidence analysis
How IRL Story Lab is Reimagining What Journalism Can Do
Investigative Reporting Lab Turns Journalism Into Award-Winning Fiction to Engage New Audiences What is established The Investigative Reporting Lab (IRL), a North Macedonian media and member of the Organized Crime and Corruption Reporting Project (OCCRP), has launched an…
Read →
Evidence analysis
As the cold season nears, universal immunisation of newborns against RSV could significantly reduce infant hospitalisations across Europe
What is established Respiratory syncytial virus (RSV) is a major cause of respiratory illness in infants, particularly during the colder months in Europe when respiratory infections rise. Hospitalisations of young children due to RSV place a significant burden…
Read →